Product Details
Would you like to give feedback on images?
|
|
Share your thoughts with other customers:
|
||||||||||||||||||||||
|
Most Helpful Customer Reviews
2 of 2 people found the following review helpful:
1.0 out of 5 stars
DVM / IVX / Teva shut down by FDA with permanent injunction,
By
This review is from: SynoviG3, 240 Soft Chews 2 Pack (Misc.)
Any manufacturer that gets to this point isn't one I want to ever trust
FDA NEWS RELEASE For Immediate Release: July 31, 2009 Media Inquiries: Michael Herndon, 301-796-4673, michael.herndon@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA Takes Action Against Teva Animal Health Inc. Company fails to adhere to current Good Manufacturing Practice regulations The U.S. Food and Drug Administration announced a consent decree of permanent injunction filed today, that prohibits Teva Animal Health Inc., its president, and two principals from its parent company, from manufacturing and distributing adulterated veterinary drugs. The injunction, once entered by the court, will prevent the defendants from manufacturing and distributing veterinary drugs until they achieve compliance with current Good Manufacturing Practice (cGMP) and obtain FDA approval. "Good manufacturing practice standards are the backbone of product quality and the instrument on which the FDA relies most heavily for assurance that veterinary drug products are safe and effective," said Bernadette Dunham, D.V.M., Ph.D., director of the FDA's Center for Veterinary Medicine. During inspections between 2007 and 2009, the FDA found significant cGMP violations at Teva Animal Health's facilities, located in St. Joseph, Mo. Under the terms of the consent decree, Teva Animal Health cannot resume manufacturing and distributing veterinary drugs until adequate methods, facilities, and controls are established and an independent expert inspects the facilities and procedures and certifies that they comply with cGMP. The FDA also will also inspect Teva Animal Health's facilities as needed before authorizing the company to resume operations. If, after resuming operations, the defendants fail to comply with any provision of the consent decree, cGMP, or the Federal Food, Drug, and Cosmetic Act, the FDA may order the company to stop manufacturing and distributing veterinary drugs, recall the products, or take other corrective actions. "The FDA will not tolerate the manufacture and distribution of adulterated animal drugs," said Michael Chappell, the FDA's acting associate commissioner for regulatory affairs. "Veterinarians and pet owners can be assured that the FDA will investigate and take regulatory actions against companies that produce animal drugs under conditions and controls that are inadequate to assure their safety and quality." In the event of future violations, the consent decree also subjects Teva Animal Health to payments of $20,000 for each day the defendants fail to comply with any provision of the decree and an additional $25,000 for each shipment of veterinary drugs in violation of the decree, up to $7.5 million per year.
2 of 2 people found the following review helpful:
1.0 out of 5 stars
Discontinued due to FDA Inspection Failue,
Amazon Verified Purchase(What's this?)
This review is from: SynoviG3, 240 Soft Chews 2 Pack (Misc.)
FDA inspection Failed so the manufacturer was forced to stop production. It's not safe to feed to your pets. I ordered the same thing, just different quantity but was only informed after the sale why it was discontinued.
1 of 1 people found the following review helpful:
5.0 out of 5 stars
cheaper than my vets office,
By
This review is from: SynoviG3, 240 Soft Chews 2 Pack (Misc.)
i was able to purchase 2 tubs of synovi g3 for the same money i pay at the vets office for one. then they recommended a product that is actually better than synovi g3, so when i need to order it again i am going to try the different product.
Share your thoughts with other customers: Create your own review
|
|
|
